Home>>Proteins>> Viral Antigens>> SARS>>CoV-2-S1 (319-541)

CoV-2-S1 (319-541)

目录号 : GP26393 复制 一键复制产品信息

The HEK293 derived recombinant protein contains the Coronavirus 2019 Spike Glycoprotein S1 Receptor Binding Domain [ RBD ], Wuhan-Hu-1 strain, amino acids 319-541 fused toHis tag at C-terminal

CoV-2-S1 (319-541) Chemical Structure

规格 价格 库存 购买数量
2μg
¥840.00
现货
10μg
¥2,030.00
现货
100μg
¥12,600.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

加载文献引用…

Description

The HEK293 derived recombinant protein contains the Coronavirus 2019 Spike Glycoprotein S1 Receptor Binding Domain [ RBD ], Wuhan-Hu-1 strain, amino acids 319-541 fused toHis tag at C-terminal.

Product Data

Purity Protein is >90% pure as determined SDS-PAGE. Source HEK293Cells.
Phycical Appearance Sterile Filtered clear solution. Shipping Condition withIcePacks
Stability CoV-2 S1RBD Protein is shipped on ice packs. Upon arrival, Store at -20°C.
Biological Activity SARS CoV-2 Spike Glycoprotein S1 RBD was tested for its biological functionality by its binding to recombinant ACE2 receptor protein confirmed by structural complementation reporter assay (NanoBiT®).
Formulation CoV-S1 RBDproteinis 1mg/ml contains 20mM sodium phosphate (NaPP), 300mM NaCl, pH7.2

Introduction

A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019.The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans.While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

Biological Activity

SARS CoV-2 Spike Glycoprotein S1 RBD was tested for its biological functionality by its binding to recombinant ACE2 receptor protein confirmed by structural complementation reporter assay (NanoBiT®).

Purification Method

Purified by Metal-Afinitychromatographic technique.

Stability

CoV-2 S1RBD Protein is shipped on ice packs. Upon arrival, Store at -20°C.

Product Documents

Quality Control & SDS

View current batch: